Kraig Biocraft Laboratories Inc (KBLB)

[Blitzed]

I think we've lost the forest for the trees here...

We shouldn't worry about the daily price, because price follows earnings. If the company makes money the share price will follow.

After this PR we have established:
Commercial production is occurring.

Massive problems such as genetic drift, mulberry supplies, and the capacity of the facility have been overcome.

There is a 40m contract to be filled.

KBL has a joint subsidiary (Spydasilk) and owns a portion of a manufacturer.

Potential new product lines will be developed in the coming years out of disease-resistant worms, large proteins from the unused goop around the cacoon, and silks with new highly specific properties that can be created with the knock-in-knock-out genetic modifications process.

A company with very little debt for its earning potential, very low expenses, and a product that may continue to be made in a very inexpensive manner. This has the makings of a cash cow when real revenues start to come in.

Massive institutions like the US military and medical companies have shown interest in the past.





The train has officially left the station. Now it is a matter of when not if. The only problem that I can see derailing the current state of affairs with KBL is if the recumbent spider silk does not test as well as traditional spider silk for the properties that make it so desirable.